Asian Spectator

Men's Weekly

.

Wesley Methodist School Kuala Lumpur (International) Breaks Record with Unity Anthology, Enters Malaysia Book of Records

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 16 September 2025 - Wesley Methodist School Kuala Lumpur (International) (WMSKLI) has etched its name in the Malaysia Book of Records (MBR) for prod...

LG Innotek Develops Automotive Lighting Module 'Nexlide-E'

SEOUL, April 21, 2021 /PRNewswire-AsiaNet/ -- --Brightness improved by 63%. Applicable to the front/rear of an automobile. --0.2mm thick optical film is used to produce a customized lighting...

California Dreaming: Battista Hits The Open Road As It Makes D...

MONTEREY, Calif., Aug. 12, 2021 /PRNewswire-AsiaNet/--- - First production-specification Automobili Pininfarina Battista has made its dynamic debut on the roads of California ahead of its ar...

JTI Awarded Top Employer 2019 in Asia Pacific Region for Fifth...

HONG KONG, Dec. 11, 2018 /PRNewswire-AsiaNet/ -- Accreditation recognizes JTI's continued commitment to employees in the region JTI (Japan Tobacco International) has been certified as Top E...

Zanoprima Lifesciences Files Patent Infringement Actions Again...

WACO, Texas, March 30, 2022 /PRNewswire-AsiaNet/ -- On March 12, 2022, Zanoprima Lifesciences Ltd. ("Zanoprima") filed a Complaint for Patent Infringement ( https://static1.squarespace.com/s...

Wilo Group Industry Conference Catalyses Collaboration for Sustainable Smart Cities Across Asia

The conference saw experts delve into the latest technologies and strategies driving the sustainable development of today’s urban areas and upcoming supercities. SINGAPORE - Media Out...

Xiamen Airlines Selects Ingenico to Optimize Global Online Payments

AMSTERDAM, NETHERLANDS - Media OutReach - 29 October 2018 - Ingenico Group(Euronext: FR0000125346 - ING), the global leader in seamless payment, today announced that it has signed a par...

LFC to face Yokohama F. Marinos on second leg of pre-season tour in Asia

LIVERPOOL, UK - Media OutReach Newswire - 10 April 2025 - Arne Slot's men will play Yokohama F. Marinos in the second game of their pre-season tour in Asia this summer. It will be the firs...

Score 11 Unbeatable Deals This 11.11 on Shopee with 90% Off Lowest Price Guaranteed

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 8 November 2024 - It’s that time of year again – Shopee’s 11.11 Big Sale, where everything you’ve been eyeing (an...

SinoMab Granted the Most Popular Newly Listed Company Award

HONG KONG, Jan 10, 2020 - (ACN Newswire) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the Group has won the title of the "Most Popular Newly Listed Company" at the 4th Hong Kong Golden Stocks Awards held in Shenzhen.

image

The 4th Hong Kong Golden Stocks Awards was jointly organized by Zhitongcaijing.com, China's leading information platform focusing on Hong Kong and US stock markets, and 10jka.com.cn. The "Most Popular Newly Listed Company" award aims at recognizing companies had been listed on Hong Kong Stock Exchange since 1 January 2019 with significant recognition from the industry, high participation of investors and excellent performance in capital markets. Being awarded the "Most Popular Newly Listed Company" demonstrates the industry and investors' close attention towards biotech industry and is a great encouragement and motivation for SinoMab's future success. SinoMab, as the first Hong Kong-listed local biopharmaceutical company, possesses several first-in-target and first-in-class drug candidates. As the drug candidate coming the closest to commercialization, the Company's flagship product SM03 is currently in Phase III clinical trial for RA in China and is expected to be marketed in 2021 the soonest. According to the latest statistics, approximately 300 patients have taken the treatment trial. Meanwhile, the Company has proactively carried out long-term development plan. Its Suzhou production base is expected to be put into operation by the end of 2021 to satisfy the commercialized production requirements of drug candidates in the future.

After three months of strict screening, the 4th Hong Kong Golden Stocks Awards attracted over 860 Hong Kong-listed companies to participate, covering emerging industries such as TMT and healthcare. The award is a recognition of SinoMab's R&D strengths, business model and industry influence from the market and investors and will help improving the Company's reputation in the capital market.

About SinoMab BioScience Limited SinoMab BioScience Limited ("SinoMab" or the "Company", stock code: 3681.HK) is dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company's flagship product SM03 is a potential global first-in-target mAb against CD22 for the treatment of rheumatoid arthritis and is currently in Phase III clinical trial for rheumatoid arthritis in China, which has been recognized as one of the significant special projects of Significant New Drugs Development of the Twelfth Five-Year Plan Period and the Thirteenth Five-Year Plan Period. In addition, the Company possesses other potential first-in-target and first-in-class drug candidates, some of which are already in clinical stage, with their indications covering rheumatoid arthritis, systemic lupus erythematosus, non-Hodgkin's lymphoma, asthma, and other diseases with major unmet clinical needs.

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Diplomasi FOMO Prabowo: Simbolis, reaktif, berisiko mengancam legitimasi

Presiden Prabowo Subianto menghadiri BRICS Leaders Virtual Meeting dari kediaman pribadinya di Kertanegara, Jakarta Selatan, pada Senin, 8 September 2025.Cahyo/Biro Pers Sekretariat Presiden, CC BY ...

Anak ikut demo: Peran negara dalam memfasilitasi dan melindungi aksi protes

(David Wadie Fisher-Freberg/Wikimedia Commons), CC BY● Banyak anak dalam demonstrasi menjadi korban kekerasan dan penyimpangan hukum.● Demonstrasi bukanlah ruang aman, tapi larangan justru...

Bagaimana revisi KUHAP bisa memperparah pelemahan KPK

(Arraihansyah/Shutterstock)● Revisi KUHAP menjadikan penyidik KPK di bawah kendali polisi, tak lagi independen.● Upaya paksa seperti penyelidikan hingga penyadapan dalam revisi KUHAP membu...